SynthesisFrontiers in oncology2022
Artificial Intelligence-Assisted Endoscopic Diagnosis of Early Upper Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.
Synthesis in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 28 citations in OpenAlex.
- Artificial Intelligence Performance in Image-Based Cancer Identification: Umbrella Review of Systematic Reviews.Journal of medical Internet research · 2025Pooled it
- Diagnostic performance of AI-assisted endoscopy diagnosis of digestive system tumors: an umbrella review.Frontiers in oncology · 2025Pooled it
- Comparative diagnostic accuracy of different artificial intelligence models for early gastric cancer: a systematic review and meta-analysis.Frontiers in oncology · 2025Pooled it
- The value of machine learning approaches in the diagnosis of early gastric cancer: a systematic review and meta-analysis.World journal of surgical oncology · 2024Pooled it
- Advanced integrated SERS-based strategies for the early diagnosis of upper gastrointestinal cancers.Journal of nanobiotechnology · 2026Review
- World Endoscopy Organization Position Statements for Artificial Intelligence in Endoscopic Diagnosis of Gastric Epithelial Neoplasia.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026Review
- Frequency and characteristics of synchronous gastric cancers: Need for improved awareness and better detection.World journal of gastrointestinal oncology · 2026Review
- Artificial Intelligence in Gastrointestinal Endoscopy: Current Advances, Clinical Integration, and Future Directions: A Narrative Review.Clinical and experimental gastroenterology · 2026Review
- Role of artificial intelligence in the detection and characterization of gastrointestinal premalignant and early malignant lesions.World journal of gastroenterology · 2025Review
- Unraveling the characteristics of early esophageal neuroendocrine carcinoma using multi-model endoscopy: A retrospective study of serial cases.World journal of gastrointestinal oncology · 2025Article
- Role of artificial intelligence in gastric diseases.World journal of gastroenterology · 2025Review
- Artificial intelligence as a predictive tool for gastric cancer: Bridging innovation, clinical translation, and ethical considerations.World journal of gastrointestinal oncology · 2025Article
- Attention-Enhanced Multi-Task Deep Learning Model for Classification and Segmentation of Esophageal Lesions.ACS omega · 2025Article
- Screening for and surveillance of premalignant conditions of the stomach.Best practice & research. Clinical gastroenterology · 2025Review
- Artificial Intelligence-Assisted Endoscopy in Diagnosis of Gastrointestinal Tumors: A Review of Systematic Reviews and Meta-Analyses.Gastro hep advances · 2025Review
- Review
- Revolutionizing healthcare by use of artificial intelligence in esophageal carcinoma - a narrative review.Annals of medicine and surgery (2012) · 2023Review
- Research trends in endoscopic applications in early gastric cancer: A bibliometric analysis of studies published from 2012 to 2022.Frontiers in oncology · 2023Review
- Global research trends of endoscope in early gastric cancer: A bibliometric and visualized analysis study over past 20 years.Frontiers in oncology · 2023Article
- Population-Based Gastric Cancer Screening in Japan: Evolution, Challenges, and Lessons for Implementation.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study was to assess the diagnostic ability of artificial intelligence (AI) in the detection of early upper gastrointestinal cancer (EUGIC) using endoscopic images. Methods: Databases were searched for studies on AI-assisted diagnosis of EUGIC using endoscopic images. The pooled area under the curve (AUC), sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) with 95% confidence interval (CI) were calculated. Results: Overall, 34 studies were included in our final analysis. Among the 17 image-based studies investigating early esophageal cancer (EEC) detection, the pooled AUC, sensitivity, specificity, PLR, NLR, and DOR were 0.98, 0.95 (95% CI, 0.95-0.96), 0.95 (95% CI, 0.94-0.95), 10.76 (95% CI, 7.33-15.79), 0.07 (95% CI, 0.04-0.11), and 173.93 (95% CI, 81.79-369.83), respectively. Among the seven patient-based studies investigating EEC detection, the pooled AUC, sensitivity, specificity, PLR, NLR, and DOR were 0.98, 0.94 (95% CI, 0.91-0.96), 0.90 (95% CI, 0.88-0.92), 6.14 (95% CI, 2.06-18.30), 0.07 (95% CI, 0.04-0.11), and 69.13 (95% CI, 14.73-324.45), respectively. Among the 15 image-based studies investigating early gastric cancer (EGC) detection, the pooled AUC, sensitivity, specificity, PLR, NLR, and DOR were 0.94, 0.87 (95% CI, 0.87-0.88), 0.88 (95% CI, 0.87-0.88), 7.20 (95% CI, 4.32-12.00), 0.14 (95% CI, 0.09-0.23), and 48.77 (95% CI, 24.98-95.19), respectively. Conclusions: On the basis of our meta-analysis, AI exhibited high accuracy in diagnosis of EUGIC. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier PROSPERO (CRD42021270443).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.